IFOSFAMIDE is a Intravenous Injection, Powder, For Solution in the Human Prescription Drug category. It is labeled and distributed by Baxter Healthcare Corporation. The primary component is Ifosfamide.
| Product ID | 10019-927_26c7c09a-3444-45f9-b8c6-6d09e719dc94 |
| NDC | 10019-927 |
| Product Type | Human Prescription Drug |
| Proprietary Name | IFOSFAMIDE |
| Generic Name | Ifosfamide |
| Dosage Form | Injection, Powder, For Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 1988-12-30 |
| Marketing Category | NDA / NDA |
| Application Number | NDA019763 |
| Labeler Name | Baxter Healthcare Corporation |
| Substance Name | IFOSFAMIDE |
| Active Ingredient Strength | 1 g/20mL |
| Pharm Classes | Alkylating Activity [MoA],Alkylating Drug [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2018-08-02 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA019763 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2018-08-02 |
| Marketing Category | NDA |
| Application Number | NDA019763 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1988-12-30 |
| Ingredient | Strength |
|---|---|
| IFOSFAMIDE | 1 g/20mL |
| SPL SET ID: | efb1d03b-2d91-406e-8110-d3a58b8fa7cc |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0143-9530 | Ifosfamide | Ifosfamide |
| 0143-9531 | Ifosfamide | Ifosfamide |
| 0703-3427 | Ifosfamide | Ifosfamide |
| 0703-3429 | Ifosfamide | Ifosfamide |
| 10019-925 | IFOSFAMIDE | IFOSFAMIDE |
| 10019-926 | IFOSFAMIDE | IFOSFAMIDE |
| 10019-927 | IFOSFAMIDE | ifosfamide |
| 10019-929 | IFOSFAMIDE | ifosfamide |
| 63323-142 | Ifosfamide | IFOSFAMIDE |
| 0338-3991 | IFEX | ifosfamide |
| 0338-3993 | IFEX | ifosfamide |